Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study.

Antibiotic-impregnated catheters Biofilm Methicillin-resistant Staphylococcus aureus Scanning electron microscope

Journal

Chinese neurosurgical journal
ISSN: 2057-4967
Titre abrégé: Chin Neurosurg J
Pays: England
ID NLM: 101672561

Informations de publication

Date de publication:
05 Jul 2022
Historique:
received: 21 09 2021
accepted: 09 06 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 6 7 2022
Statut: epublish

Résumé

Shunt systems are used to provide cerebrospinal fluid drainage in the treatment of hydrocephalus. Recently, antibiotic-impregnated shunt systems are used to prevent colonization in the ventriculoperitoneal catheters. Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative microorganism of shunt infections. The aim of the study is to investigate effects of several substances on MRSA biofilms in the ventriculoperitoneal catheters. The present study consists of mainly eight groups (each has two subgroups as antibiotic-impregnated and nonantibiotic-impregnated catheters). In addition, each group contains six molds using MRSA strains. In this study, daptomycin (DAPT) (2 mg/ml), vancomycin (VAN) (10 mg/ml), linezolid (LIN) (2 mg/ml), N-acetylcysteine (NAC) (6 mg/ml), and various combinations of these substances were used to evaluate the treatment against MRSA using scanning electron microscope (SEM) images and microbiological enumeration. The colony count in the antibiotic-impregnated samples significantly decreased compared to nonantibiotic-impregnated samples in the MRSA, MRSA + DAPT, and MRSA + LIN groups (p < 0.01), respectively. Conversely, the colony count in antibiotic-impregnated samples significantly increased compared to nonantibiotic-impregnated samples in NAC + DAPT and NAC + VAN groups (p < 0.01), respectively. The results showed that the use of antibiotic-impregnated catheters has a significant impact on the prevention of infection whereas the combination of NAC and DAPT showed better antibiofilm and antibacterial effects than other combinations on the prevention and treatment of nonantibiotic-impregnated catheter infections.

Sections du résumé

BACKGROUND BACKGROUND
Shunt systems are used to provide cerebrospinal fluid drainage in the treatment of hydrocephalus. Recently, antibiotic-impregnated shunt systems are used to prevent colonization in the ventriculoperitoneal catheters. Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative microorganism of shunt infections. The aim of the study is to investigate effects of several substances on MRSA biofilms in the ventriculoperitoneal catheters.
METHODS METHODS
The present study consists of mainly eight groups (each has two subgroups as antibiotic-impregnated and nonantibiotic-impregnated catheters). In addition, each group contains six molds using MRSA strains. In this study, daptomycin (DAPT) (2 mg/ml), vancomycin (VAN) (10 mg/ml), linezolid (LIN) (2 mg/ml), N-acetylcysteine (NAC) (6 mg/ml), and various combinations of these substances were used to evaluate the treatment against MRSA using scanning electron microscope (SEM) images and microbiological enumeration.
RESULTS RESULTS
The colony count in the antibiotic-impregnated samples significantly decreased compared to nonantibiotic-impregnated samples in the MRSA, MRSA + DAPT, and MRSA + LIN groups (p < 0.01), respectively. Conversely, the colony count in antibiotic-impregnated samples significantly increased compared to nonantibiotic-impregnated samples in NAC + DAPT and NAC + VAN groups (p < 0.01), respectively.
CONCLUSIONS CONCLUSIONS
The results showed that the use of antibiotic-impregnated catheters has a significant impact on the prevention of infection whereas the combination of NAC and DAPT showed better antibiofilm and antibacterial effects than other combinations on the prevention and treatment of nonantibiotic-impregnated catheter infections.

Identifiants

pubmed: 35791005
doi: 10.1186/s41016-022-00284-2
pii: 10.1186/s41016-022-00284-2
pmc: PMC9254433
doi:

Types de publication

Journal Article

Langues

eng

Pagination

15

Informations de copyright

© 2022. The Author(s).

Références

Scanning. 2016 Nov;38(6):766-770
pubmed: 27186786
J Neurol Neurosurg Psychiatry. 1989 May;52(5):605-9
pubmed: 2732730
Acta Neurochir (Wien). 2012 Sep;154(9):1691-7
pubmed: 22454037
J Neurosurg. 2005 Aug;103(2 Suppl):113-8
pubmed: 16370275
Clin Infect Dis. 2002 Jun 1;34(11):1481-90
pubmed: 12015695
Antimicrob Agents Chemother. 2006 Mar;50(3):1079-82
pubmed: 16495273
J Neurosurg Pediatr. 2010 Sep;6(3):277-85
pubmed: 20809713
Medicine (Baltimore). 2010 Mar;89(2):117-125
pubmed: 20517182
J Neurosurg. 1997 Aug;87(2):247-51
pubmed: 9254088
Antimicrob Agents Chemother. 2006 May;50(5):1865-8
pubmed: 16641463
Pediatr Neurosurg. 2003 Dec;39(6):285-90
pubmed: 14734861
Antimicrob Agents Chemother. 2006 Jun;50(6):2225-7
pubmed: 16723590
Childs Nerv Syst. 2009 Jan;25(1):77-83; discussion 85
pubmed: 18985357
Wound Repair Regen. 2007 Jan-Feb;15(1):80-6
pubmed: 17244323
Indian J Med Microbiol. 2006 Jan;24(1):52-4
pubmed: 16505557
Clin Pediatr (Phila). 2006 Oct;45(8):705-13
pubmed: 16968955
Childs Nerv Syst. 2007 Jul;23(7):773-7
pubmed: 17285349
J Korean Med Sci. 2012 Dec;27(12):1563-8
pubmed: 23255859
Microb Pathog. 2017 Apr;105:145-152
pubmed: 28237766
Clin Infect Dis. 2004 Feb 15;38(4):521-8
pubmed: 14765345
BMC Infect Dis. 2007 May 08;7:38
pubmed: 17488498
Clin Microbiol Rev. 2013 Oct;26(4):759-80
pubmed: 24092854
J Clin Neurosci. 2007 Jun;14(6):526-31
pubmed: 17430776
N Engl J Med. 2006 Aug 17;355(7):653-65
pubmed: 16914701
J Neurosurg. 2003 Nov;99(5):831-9
pubmed: 14609161
Childs Nerv Syst. 2015 Jul;31(7):1129-38
pubmed: 25820704
J Neurosurg. 2005 Aug;103(2 Suppl):131-6
pubmed: 16370278
Antimicrob Agents Chemother. 2006 Dec;50(12):4195-7
pubmed: 17043121
J Antimicrob Chemother. 1997 May;39(5):643-6
pubmed: 9184365
Neurosurgery. 2006 May;58(5):930-5; discussion 930-5
pubmed: 16639329
Antimicrob Agents Chemother. 2012 Jun;56(6):2842-5
pubmed: 22430965
Neurosurgery. 2006 Apr;58(4):657-65; discussion 657-65
pubmed: 16575329

Auteurs

Tuba Kuruoglu (T)

Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Ondokuz Mayıs University, Samsun, Turkey.

Gamze Altun (G)

Department of Histology and Embryology, Medical Faculty, Ondokuz Mayıs University, 55139, Samsun, Turkey.

Enis Kuruoglu (E)

Department of Neurosurgery, Medical Faculty, Ondokuz Mayıs University, Samsun, Turkey.

Derya Bayırlı Turan (DB)

Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Yeni Yuzyil University, Istanbul, Turkey.

Mehmet Emin Önger (ME)

Department of Histology and Embryology, Medical Faculty, Ondokuz Mayıs University, 55139, Samsun, Turkey. mehmetemin.onger@gmail.com.
Department of Neuroscience, Health Science Institute, Ondokuz Mayıs University, Samsun, Turkey. mehmetemin.onger@gmail.com.

Classifications MeSH